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Legendary Inheritance of Sex, Violence 
and Tragedy Surrounding Staphylus
Zeus Semele Minos Pasiphaë
Supreme ruler Mortal priestess King of Crete
Mt. Olympus Asked Zeus to reveal
Married to Hera his glory -
Numerous liaisons Bolts of lightning
Father to Helen led to death
Dionysus Ariadne
God of wine Loved Theseus
Hera had Titan lure who "had no
and attack him joy for her"
remaining heart back on Naxos
into Semele. "Twice born"
Staphylus
God of wine




Some in indigo-colored clumps





Scot Med J 1998; 43:156-7
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case fatality = 82%
age strata
Skinner & Keefer
Arch Int. Med 1941; 68: 851-75
Antibiotic Resistance in S. aureus
 Following the Great Discovery of Penicillin
Abraham and Chain
Nature 1940; 146:837-
"An enzyme from bacteria
Able to destroy Penicillin"
Extract of E. coli with a
"substance destroying 


























6                            < 6 MIC (g/mL)
To Penicillin
% survival






















penicillin                     attributable mortality
31%
51%
Arch Int Med 1941; 68:851-75
Arch Int Med 1959; 104:226-73
Staphylococcal Toxin* 
by P.N. Panton and F.C. O. Valentine
Denys and Van de Velde
 
in 1895 described destruction of 




7/22 strains: strong leukoidin, weak hemolysis
6/7 severe infections, all 4 "pyemic" cases and
2/4 rapidly fatal after carbuncle







"chiefly efficacious with pyemic
 
cases" in man
Lancet 1932 (March 5): 5068
* Gene later found to be on a phage virus integrated to Staph
Penicillin-Resistant S. aureus: 





























Half of UK outbreaks
1/3 colonized -> BSI
2.5% if non 80/81
Lancet 1959; 1:190-5 Sci Based Med Ann Rev 1966; 157:73
BMJ 1959; 5153:658-62     Lancet 2005; 365:1256-8


























































secrete family of heat-stable
protease 
pheromones (5 to 6) -
 

















Cell 1993; 77: 9-12



























































































USA 300 – 97%
SCC IV, PVL – 98%
USA 300 – 31%
PVL – 42%
S.aureus - 76% SSTI
(MRSA 59%)
Comparison of USA300 and USA400 lethality
 *P<.01, Fisher's exact test.
Montgomery et al JID 2008; 198:561-70
USA 300 More Virulent than USA 400 
Rat Pneumonia Model
Descendants of 80/81 Re-Emerging as CA-
 MRSA:
 










































infections and modern hospitals 
have been constant companions

 




Evolution of S. aureus
 
is clonal







80/81) are more virulent, spread more 
rapidly than others, and dominate
The Role of Modern Infection Control
APIC




















Testing the interventions (intervention)





































Silk Sutures Reduce 



























and Conan Brit J Exp Path 1957; 38: 573-86
Tied suture 3 x 104
 
organisms:
2/2 "very large stitch abscess"






















had same strain in nose






Chr. Danbolt, PhD, University of Oslo
Median of 55% of  S.aureus

















Author     Williams   PHL  Henderson McNell
 
Bassett   White    Calia
Wenzel and Perl J Hosp infect 1995; 31:13-24
55





Elimination of Coincident S. aureus Nasal 
and Hand Carriage with Mupirocin















































placebo            Mupirocin
 
placebo
n=1933         n=1931             n=444             n=447






Subset of S.epidermidis Secrete Esp
 Inhibiting S.aureus Nasal Colonization





If colonized with inhibitory S. epi
OR=0.30 for S. aureus
 
colonization
Esp, serine protease, plus peptide component of 










Iwase et al Nature 20 May 2010
Doi:10.1038/nature09074
Host Genetics May Determine
 
Persistent
 S. Aureus Carriage
Persistant
 












A significant association with persistent carriage (2006 and 
2008) and sets of single nucleotide polymorphisms to 

















only outer portions of hair 
follicle




J Hosp Infect 2010; 
76:211-4
Preventing Surgical-Site Infections in 













(n=413)                 (n=504)
n=32
n=17
o ~60% reduction of S aureus infections
o 79% reduction in deep SSI
o 55% reduction in superficial SSIs









 Iodine for Surgical-Site Antisepsis
o
 
Clean-contaminated surgery, randomly assigned to 
preoperative skin prep with either chlorhexidine-alcohol or 


























Alcohol (n=391)      Iodine (n=422)






Estimates of S aureus Infections 
Using Two Different Programs
A horizontal program reduces all infections at a specific anatomic site, whereas a 
Vertical program targets a single organism at that site.




40% of ALL SSIs
 
can be eliminated with a 
change in surgical scrub from Iodophor
 
to 
Chlorhexidine-Alcohol; 60% of S. aureus
 
SSIs








Combining both approaches might yield a 50% 
absolute reduction of all SSIs.
Increasing Antibiotic Resistance 
Strains 1970-2010
Wenzel et al ICHE 2008; 29:1012-8
Health care associated MRSA 2005-2008: 28% decline in US
Kallen
 
et al JAMA 2010; 304:641-8
The Shortcomings of Nasal 
Screening for S. aureus/MRSA
Throat carriage only in S.aureus: 25%
MRSA throat carriage only: 13-15%
Arch Internal Medicine 2009; 169:172-8
Journal of Clinical Microbiology 2008; 46:835
Journal of Clinical Microbiology 227; 45:385
CA-MRSA in Nares
 




carriage have same risk as
nasal carriage?
Decline in Invasive MRSA Infections
CDC’s population-based surveillance 
2005-08: Decline 9.4%/yr 
most prominent for BSIs
28% decline over 4 years
National decline of MRSA BSI
2003-08: 57%
Declines began prior to MRSA-
specific interventions





JAC 2009; 64 (supp 1):111-7
JAMA 2010; 304:687-9





S.aureus Enterococcus Candida                   GNR






ICU-related MDR A. baumannii Colonization 













4.6% => 0.6% (OR=7.6, p<.001)




7.8 to 1.25/1000 pt-days (85% reduction)
Borer et al. J Hosp. Infect 2007; 67:149-55
Could Daily Bathing with 
Chlorhexidine
 
Reduce MRSA and 
VRE Acquisition and Infections?
In quasi-experimental study 
6 mo reg
 
soap => 6 mo chlorhexidine
►MRSA acquisition decreased 32%
► VRE acquisition decreased 50%
► VRE BSI decreased 73%
Crit Care Med 2009; 37:1858-65
Medical College of Virginia Hospital  
Evidence-Based Interventions 
(without active surveillance for MRSA)
Neuroscience, Medical, Surgical ICUs
Device-related BSI, urine infections and VAPs
 
fell 
> 40% in each unit and MRSA infects fell >48% 
in each unit
Edmond et al Am J Infect Control 2008 ; 36:461-3
1 July 2010: 914 days in MRICU wince 
VAP case
66% Reduction in all Catheter-



























Clean Part With Alcohol
Avoid 3-Way MPS
Needless Adaptors For Ports
Inspect/Clean Site Daily
Dedicated Lumen For TPNBMJ Qual Saf 2011; 20: 174-80
Figure 1
All or none insertion bundle reliability over time annotated to show identification and 
resolution of causes of incomplete reliability. Detail is given in the online appendix 6. 
Reliability increased between March 2008 and August 2009. 
BMJ Qual Saf 2011;20:174-180. doi:10.1136/bmjqs.2009.037200
Figure 2
U chart. Monthly central-venous-catheter-related bloodstream infection (CRBSI) 
acquisition as rate per device day (number of infections divided
 
by the device 
days/month). The plot demonstrates the common cause variation before the interventions 
start. Special cause variation (downwards shift) is evidenced by
 
a run of >6 points below 






BMJ Qual Saf 2011;20:174-180. doi:10.1136/bmjqs.2009.037200
Reducing Ventilator-Associated
 Pneumonia by 71% -
 
Cohort Study


















Prophylaxis to decrease DVTs
Caveats: No controls; no uniform surveillance 
definition ICHE 2011; 32:305-14
Reducing Ventilator Associated
 Pneumonia by 71% -
 
Cohort Study
Why Do Horizontal Programs Work?
 They Are Population-based: BSI example
Comparison of infection control approaches assuming 10,000 admissions 

























National estimates of lives saved
(assume 35 million admissions –





Wenzel et al. ICHE 2008; 29:1012-18
Controlling Pathogens in the Hospital: 
Vertical vs. Horizontal Approach
MRSA MSSA VRE Acinetobacter
Controlling Pathogens in the Hospital: 
Vertical vs. Horizontal Approach
MRSA MSSA VRE Acinetobacter
Infection Control in 2011
Current data support the argument 
that we have the ability to reduce 
all nosocomial
 
infections by 50%, 
including MRSA, VRE, 
and MDR Acinetobacter









How do we prevent the existing infections by 
another 50% in the next 3-4 years… achieving a 
75% total reduction by 2014-2015?
Key Infection Control Safety Question
On a platform of an effective infection control program 
(~ 50% reduction in all
 
infections every 3-4 years), 
what is the incremental value of an adjunctive 
vertical program (MRSA screening)?

















Lancet Inf Dis 2010; 10:597-602
NDM-1 in India, Pakistan, and UK
Numbers of carbapenemase-producing 
Enterobacteriaceae
 
referred from UK 
laboratories to the UK Health Protection 
Agency's national reference laboratory from 
2003 to 2009. The predominant gene is 
blaNDM-1, which was first identified in 2008. 
The other group includes diverse producers of 





strains in Bangladesh, India, 
Pakistan, and the UK 




Can we begin to think about 
infection control and 




Can we construct global 
health policies and strategies 
that benefit the developing 
and developed world 
equally? 
